Lewis McCurdy
Overview
Explore the profile of Lewis McCurdy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sension M, Brunet L, Hsu R, Fusco J, Cochran Q, Uranaka C, et al.
Infect Dis Ther
. 2023 Nov;
12(12):2807-2817.
PMID: 37966701
Introduction: The first complete long-acting antiretroviral therapy (ART) regimen, cabotegravir + rilpivirine long-acting (CAB + RPV LA) injectable, was approved in the US for HIV-1 treatment in individuals on a...
2.
Speight C, Williamson J, Ebied A, Medaris L, McCurdy L, Hammer K
Open Forum Infect Dis
. 2023 Aug;
10(8):ofad388.
PMID: 37555131
Background: Infectious diseases consultation improves outcomes in patients with candidemia, although some facilities lack access to consultation. This multisite health care system study compared in-hospital mortality in patients with candidemia...
3.
Priem J, Krinner L, Constantine S, McCurdy L
Dialogues Health
. 2023 Mar;
1:100017.
PMID: 36942315
Access to SARS-CoV-2 testing is a crucial component of early identification and disease containment. Racial and ethnic health disparities exist related to testing utilization. To optimize testing with limited resources,...
4.
Polk C, Sampson M, Fairman R, DeWitt M, Leonard M, Neelakanta A, et al.
Ther Adv Infect Dis
. 2023 Mar;
10:20499361231158463.
PMID: 36911268
Objective: Emerging infectious diseases challenge healthcare systems to implement new models of care. We aim to evaluate the rapid implementation of a new care model for monkeypox in our health...
5.
Sampson M, Polk C, Fairman R, DeWitt M, Leonard M, Davidson L, et al.
Infect Control Hosp Epidemiol
. 2022 Sep;
44(2):348-349.
PMID: 36102128
No abstract available.
6.
Mounzer K, Brunet L, Fusco J, McNicholl I, Cuervo H, Sension M, et al.
Open Forum Infect Dis
. 2022 Feb;
9(3):ofac018.
PMID: 35169590
Background: Approximately 20% of newly diagnosed people with HIV (PWH) in the United States have advanced HIV infection, yet the literature on current antiretroviral therapy (ART) options is limited. The...
7.
Passaretti C, Priem J, Agner T, McCurdy L
Vaccine
. 2022 Feb;
40(9):1213-1214.
PMID: 35115196
Objective: To determine the impact of COVID-19 vaccination oninfectionratesin healthcare workers(HCWs) with a householdexposure. Methods: Retrospectivecohort study8410HCWs(400 fullyvaccinated, 1645partially vaccinated,6365 unvaccinated),employed by a large integrated healthcare system in the southeastern...
8.
Taylor S, Murphy S, Rios A, McWilliams A, McCurdy L, Chou S, et al.
Crit Care Med
. 2021 Sep;
50(3):469-479.
PMID: 34534130
Objectives: To evaluate whether a nurse navigator-led, multicomponent Sepsis Transition And Recovery program improves 30-day mortality and readmission outcomes after sepsis hospitalization. Desig: n: Multisite pragmatic randomized clinical trial. Setting:...
9.
Meredith J, Onsrud J, Davidson L, Medaris L, Kowalkowski M, Fischer K, et al.
Open Forum Infect Dis
. 2021 Jun;
8(6):ofab229.
PMID: 34189171
Background: Telemedicine (TM) programs can be implemented to deliver specialty care through virtual platforms and overcome geographic/resource constraints. Few data exist to describe outcomes associated with TM-based infectious diseases (ID)...
10.
Kowalkowski M, Eaton T, McWilliams A, Tapp H, Rios A, Murphy S, et al.
BMC Health Serv Res
. 2021 Jun;
21(1):544.
PMID: 34078374
Background: Sepsis survivors experience high morbidity and mortality, and healthcare systems lack effective strategies to address patient needs after hospital discharge. The Sepsis Transition and Recovery (STAR) program is a...